Industry Research Reports

Home > Reports > Pharma & Healthcare > Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Pharma & Healthcare

Published Date: 2026-07-14

Pages: 122 Pages

Report ld: 6939833

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Alimta was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

The North American market for Alimta was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Alimta was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Alimta was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Alimta market include Eli Lilly, Abbott Healthcare, Cadila Healthcare, Eagle Pharmaceuticals, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Alimta, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Alimta market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Alimta.

Market Segmentation

By Company

Eli Lilly
Abbott Healthcare
Cadila Healthcare
Eagle Pharmaceuticals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

100mg
500mg

Segment by Application

Pleural Mesothelioma
Non-small Cell Lung Cancer

biaoTi Chapter Outline

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Alimta manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Alimta sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Alimta sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYResearch's Strengths

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Alimta Product Introduction

1.2 Global Alimta Market Size Forecast

1.2.1 Global Alimta Sales Value (2021–2032)

1.2.2 Global Alimta Sales Volume (2021–2032)

1.2.3 Global Alimta Sales Price (2021–2032)

1.3 Alimta Market Trends & Drivers

1.3.1 Alimta Industry Trends

1.3.2 Alimta Market Drivers & Opportunities

1.3.3 Alimta Market Challenges

1.3.4 Alimta Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Alimta Players Revenue Ranking (2025)

2.2 Global Alimta Revenue by Company (2021–2026)

2.3 Global Alimta Sales Volume Ranking of Players (2025)

2.4 Global Alimta Sales Volume by Company (2021–2026)

2.5 Global Alimta Average Price by Company (2021–2026)

2.6 Key Manufacturers Alimta Manufacturing Base and Headquarters

2.7 Key Manufacturers Alimta Product Offerings

2.8 Key Manufacturers Start of Mass Production of Alimta

2.9 Alimta Market Competitive Analysis

2.9.1 Alimta Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Alimta Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alimta revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Alimta Market Classification

3.1 Introduction by Type

3.1.1 100mg

3.1.2 500mg

3.1.3 Global Alimta Sales Value by Type

3.1.3.1 Global Alimta Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Alimta Sales Value, by Type (2021–2032)

3.1.3.3 Global Alimta Sales Value, by Type (%), 2021–2032

3.1.4 Global Alimta Sales Volume by Type

3.1.4.1 Global Alimta Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Alimta Sales Volume, by Type (2021–2032)

3.1.4.3 Global Alimta Sales Volume, by Type (%), 2021–2032

3.1.5 Global Alimta Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Pleural Mesothelioma

4.1.2 Non-small Cell Lung Cancer

4.2 Global Alimta Sales Value by Application

4.2.1 Global Alimta Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Alimta Sales Value, by Application (2021–2032)

4.2.3 Global Alimta Sales Value, by Application (%), 2021–2032

4.3 Global Alimta Sales Volume by Application

4.3.1 Global Alimta Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Alimta Sales Volume, by Application (2021–2032)

4.3.3 Global Alimta Sales Volume, by Application (%), 2021–2032

4.4 Global Alimta Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Alimta Sales Value by Region

5.1.1 Global Alimta Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Alimta Sales Value by Region (2021–2026)

5.1.3 Global Alimta Sales Value by Region (2027–2032)

5.1.4 Global Alimta Sales Value by Region (%), 2021–2032

5.2 Global Alimta Sales Volume by Region

5.2.1 Global Alimta Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Alimta Sales Volume by Region (2021–2026)

5.2.3 Global Alimta Sales Volume by Region (2027–2032)

5.2.4 Global Alimta Sales Volume by Region (%), 2021–2032

5.3 Global Alimta Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Alimta Sales Value, 2021–2032

5.4.2 North America Alimta Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Alimta Sales Value, 2021–2032

5.5.2 Europe Alimta Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Alimta Sales Value, 2021–2032

5.6.2 Asia Pacific Alimta Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Alimta Sales Value, 2021–2032

5.7.2 South America Alimta Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Alimta Sales Value, 2021–2032

5.8.2 Middle East & Africa Alimta Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Alimta Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Alimta Sales Value and Sales Volume

6.2.1 Key Countries/Regions Alimta Sales Value, 2021–2032

6.2.2 Key Countries/Regions Alimta Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Alimta Sales Value, 2021–2032

6.3.2 United States Alimta Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Alimta Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Alimta Sales Value, 2021–2032

6.4.2 Europe Alimta Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Alimta Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Alimta Sales Value, 2021–2032

6.5.2 China Alimta Sales Value by Type (%), 2025 vs 2032

6.5.3 China Alimta Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Alimta Sales Value, 2021–2032

6.6.2 Japan Alimta Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Alimta Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Alimta Sales Value, 2021–2032

6.7.2 South Korea Alimta Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Alimta Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Alimta Sales Value, 2021–2032

6.8.2 Southeast Asia Alimta Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Alimta Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Alimta Sales Value, 2021–2032

6.9.2 India Alimta Sales Value by Type (%), 2025 vs 2032

6.9.3 India Alimta Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Eli Lilly

7.1.1 Eli Lilly Company Information

7.1.2 Eli Lilly Introduction and Business Overview

7.1.3 Eli Lilly Alimta Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Eli Lilly Alimta Product Offerings

7.1.5 Eli Lilly Recent Developments

7.2 Abbott Healthcare

7.2.1 Abbott Healthcare Company Information

7.2.2 Abbott Healthcare Introduction and Business Overview

7.2.3 Abbott Healthcare Alimta Sales, Revenue, Price and Gross Margin (2021–2026)

7.2.4 Abbott Healthcare Alimta Product Offerings

7.2.5 Abbott Healthcare Recent Developments

7.3 Cadila Healthcare

7.3.1 Cadila Healthcare Company Information

7.3.2 Cadila Healthcare Introduction and Business Overview

7.3.3 Cadila Healthcare Alimta Sales, Revenue, Price and Gross Margin (2021–2026)

7.3.4 Cadila Healthcare Alimta Product Offerings

7.3.5 Cadila Healthcare Recent Developments

7.4 Eagle Pharmaceuticals

7.4.1 Eagle Pharmaceuticals Company Information

7.4.2 Eagle Pharmaceuticals Introduction and Business Overview

7.4.3 Eagle Pharmaceuticals Alimta Sales, Revenue, Price and Gross Margin (2021–2026)

7.4.4 Eagle Pharmaceuticals Alimta Product Offerings

7.4.5 Eagle Pharmaceuticals Recent Developments

8 Industry Chain Analysis

8.1 Alimta Industrial Chain

8.2 Alimta Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Alimta Sales Model

8.5.2 Sales Channels

8.5.3 Alimta Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Alimta Market Trends

Table 2. Alimta Market Drivers & Opportunities

Table 3. Alimta Market Challenges

Table 4. Alimta Market Restraints

Table 5. Global Alimta Revenue by Company (US$ Million), 2021–2026

Table 6. Global Alimta Revenue Market Share by Company (2021–2026)

Table 7. Global Alimta Sales Volume by Company (Kg), 2021–2026

Table 8. Global Alimta Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Alimta Price by Company (USD/g), 2021–2026

Table 10. Key Manufacturers Alimta Manufacturing Base and Headquarters

Table 11. Key Manufacturers Alimta Product Type

Table 12. Key Manufacturers Start of Mass Production of Alimta

Table 13. Global Alimta Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Alimta revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Alimta Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Alimta Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Alimta Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Alimta Sales Market Share in Value by Type (2021–2026)

Table 20. Global Alimta Sales Market Share in Value by Type (2027–2032)

Table 21. Global Alimta Sales Volume by Type: 2021 vs 2025 vs 2032 (Kg)

Table 22. Global Alimta Sales Volume by Type (Kg), 2021–2026

Table 23. Global Alimta Sales Volume by Type (Kg), 2027–2032

Table 24. Global Alimta Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Alimta Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Alimta Price by Type (USD/g), 2021–2026

Table 27. Global Alimta Price by Type (USD/g), 2027–2032

Table 28. Global Alimta Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Alimta Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Alimta Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Alimta Sales Market Share in Value by Application (2021–2026)

Table 32. Global Alimta Sales Market Share in Value by Application (2027–2032)

Table 33. Global Alimta Sales Volume by Application: 2021 vs 2025 vs 2032 (Kg)

Table 34. Global Alimta Sales Volume by Application (Kg), 2021–2026

Table 35. Global Alimta Sales Volume by Application (Kg), 2027–2032

Table 36. Global Alimta Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Alimta Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Alimta Price by Application (USD/g), 2021–2026

Table 39. Global Alimta Price by Application (USD/g), 2027–2032

Table 40. Global Alimta Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Alimta Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Alimta Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Alimta Sales Value by Region (%), 2021–2026

Table 44. Global Alimta Sales Value by Region (%), 2027–2032

Table 45. Global Alimta Sales Volume by Region (Kg): 2021 vs 2025 vs 2032

Table 46. Global Alimta Sales Volume by Region (Kg), 2021–2026

Table 47. Global Alimta Sales Volume by Region (Kg), 2027–2032

Table 48. Global Alimta Sales Volume by Region (%), 2021–2026

Table 49. Global Alimta Sales Volume by Region (%), 2027–2032

Table 50. Global Alimta Average Price by Region (USD/g), 2021–2026

Table 51. Global Alimta Average Price by Region (USD/g), 2027–2032

Table 52. Key Countries/Regions Alimta Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Alimta Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Alimta Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Alimta Sales Volume, (Kg), 2021–2026

Table 56. Key Countries/Regions Alimta Sales Volume, (Kg), 2027–2032

Table 57. Eli Lilly Company Information

Table 58. Eli Lilly Introduction and Business Overview

Table 59. Eli Lilly Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021–2026)

Table 60. Eli Lilly Alimta Product Offerings

Table 61. Eli Lilly Recent Developments

Table 62. Abbott Healthcare Company Information

Table 63. Abbott Healthcare Introduction and Business Overview

Table 64. Abbott Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021–2026)

Table 65. Abbott Healthcare Alimta Product Offerings

Table 66. Abbott Healthcare Recent Developments

Table 67. Cadila Healthcare Company Information

Table 68. Cadila Healthcare Introduction and Business Overview

Table 69. Cadila Healthcare Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021–2026)

Table 70. Cadila Healthcare Alimta Product Offerings

Table 71. Cadila Healthcare Recent Developments

Table 72. Eagle Pharmaceuticals Company Information

Table 73. Eagle Pharmaceuticals Introduction and Business Overview

Table 74. Eagle Pharmaceuticals Alimta Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2021–2026)

Table 75. Eagle Pharmaceuticals Alimta Product Offerings

Table 76. Eagle Pharmaceuticals Recent Developments

Table 77. Key Raw Materials Lists

Table 78. Key Suppliers of Raw Materials Lists

Table 79. Alimta Downstream Customers

Table 80. Alimta Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Alimta Product Picture

Figure 2. Global Alimta Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Alimta Sales Value (US$ Million), 2021–2032

Figure 4. Global Alimta Sales Volume (Kg), 2021–2032

Figure 5. Global Alimta Sales Price (USD/g), 2021–2032

Figure 6. Alimta Report Years Considered

Figure 7. Global Alimta Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Alimta Sales Volume Ranking of Players (Kg), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Alimta Revenue in 2025

Figure 10. Alimta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. 100mg Picture

Figure 12. 500mg Picture

Figure 13. Global Alimta Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Alimta Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Alimta Sales Volume by Type (Kg), 2021 vs 2025 vs 2032

Figure 16. Global Alimta Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Alimta Price by Type (USD/g), 2021–2032

Figure 18. Product Picture of Pleural Mesothelioma

Figure 19. Product Picture of Non-small Cell Lung Cancer

Figure 20. Global Alimta Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Alimta Sales Value Market Share by Application, 2025 & 2032

Figure 22. Global Alimta Sales Volume by Application (Kg), 2021 vs 2025 vs 2032

Figure 23. Global Alimta Sales Volume Market Share by Application, 2025 & 2032

Figure 24. Global Alimta Price by Application (USD/g), 2021–2032

Figure 25. North America Alimta Sales Value (US$ Million), 2021–2032

Figure 26. North America Alimta Sales Value by Country (%), 2025 vs 2032

Figure 27. Europe Alimta Sales Value (US$ Million), 2021–2032

Figure 28. Europe Alimta Sales Value by Country (%), 2025 vs 2032

Figure 29. Asia Pacific Alimta Sales Value (US$ Million), 2021–2032

Figure 30. Asia Pacific Alimta Sales Value by Region (%), 2025 vs 2032

Figure 31. South America Alimta Sales Value (US$ Million), 2021–2032

Figure 32. South America Alimta Sales Value by Country (%), 2025 vs 2032

Figure 33. Middle East & Africa Alimta Sales Value (US$ Million), 2021–2032

Figure 34. Middle East & Africa Alimta Sales Value by Country (%), 2025 vs 2032

Figure 35. Key Countries/Regions Alimta Sales Value (%), 2021–2032

Figure 36. Key Countries/Regions Alimta Sales Volume (%), 2021–2032

Figure 37. United States Alimta Sales Value (US$ Million), 2021–2032

Figure 38. United States Alimta Sales Value by Type (%), 2025 vs 2032

Figure 39. United States Alimta Sales Value by Application (%), 2025 vs 2032

Figure 40. Europe Alimta Sales Value (US$ Million), 2021–2032

Figure 41. Europe Alimta Sales Value by Type (%), 2025 vs 2032

Figure 42. Europe Alimta Sales Value by Application (%), 2025 vs 2032

Figure 43. China Alimta Sales Value (US$ Million), 2021–2032

Figure 44. China Alimta Sales Value by Type (%), 2025 vs 2032

Figure 45. China Alimta Sales Value by Application (%), 2025 vs 2032

Figure 46. Japan Alimta Sales Value (US$ Million), 2021–2032

Figure 47. Japan Alimta Sales Value by Type (%), 2025 vs 2032

Figure 48. Japan Alimta Sales Value by Application (%), 2025 vs 2032

Figure 49. South Korea Alimta Sales Value (US$ Million), 2021–2032

Figure 50. South Korea Alimta Sales Value by Type (%), 2025 vs 2032

Figure 51. South Korea Alimta Sales Value by Application (%), 2025 vs 2032

Figure 52. Southeast Asia Alimta Sales Value (US$ Million), 2021–2032

Figure 53. Southeast Asia Alimta Sales Value by Type (%), 2025 vs 2032

Figure 54. Southeast Asia Alimta Sales Value by Application (%), 2025 vs 2032

Figure 55. India Alimta Sales Value (US$ Million), 2021–2032

Figure 56. India Alimta Sales Value by Type (%), 2025 vs 2032

Figure 57. India Alimta Sales Value by Application (%), 2025 vs 2032

Figure 58. Alimta Industrial Chain

Figure 59. Alimta Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

Related Reports

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-04
Pages: 74
USD 2900.00
(Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-01-24
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published Date: 2024-04-15
Pages: 76
USD 4900.00
(Single User License)
Global Alimta Market Research Report 2025
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-25
Pages: 69
USD 2900.00
(Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 85
USD 3950.00
(Single User License)
Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 71
USD 4250.00
(Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 97
USD 2900.00
(Single User License)

Global Alimta Market Research Report 2024
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-04
Pages: 74
USD 2900.00 (Single User License)
Alimta - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-01-24
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Market Insights, Forecast to 2030
Alimta is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Published: 2024-04-15
Pages: 76
USD 4900.00 (Single User License)
Global Alimta Market Research Report 2025
The global market for Alimta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-25
Pages: 69
USD 2900.00 (Single User License)
Alimta- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Alimta was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 85
USD 3950.00 (Single User License)
Global Alimta Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Alimta market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 71
USD 4250.00 (Single User License)
Global Alimta Market Research Report 2026
The global Alimta market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 97
USD 2900.00 (Single User License)